Following a single blind, cross-over and non-randomized design we investigated the effect of 7-day use of chlorhexidine (CHX) mouthwash on the salivary microbiome as well as several saliva and plasma biomarkers in 36 healthy individuals. They rinsed their mouth (for 1 min) twice a day for seven days with a placebo mouthwash and then repeated this protocol with CHX mouthwash for a further seven days. Saliva and blood samples were taken at the end of each treatment to analyse the abundance and diversity of oral bacteria, and pH, lactate, glucose, nitrate and nitrite concentrations. CHX significantly increased the abundance of Firmicutes and Proteobacteria, and reduced the content of Bacteroidetes, TM7, SR1 and Fusobacteria. This shift was associated with a significant decrease in saliva pH and buffering capacity, accompanied by an increase in saliva lactate and glucose levels. Lower saliva and plasma nitrite concentrations were found after using CHX, followed by a trend of increased systolic blood pressure. Overall, this study demonstrates that mouthwash containing CHX is associated with a major shift in the salivary microbiome, leading to more acidic conditions and lower nitrite availability in healthy individuals.
Results
Thirty six healthy participants successfully completed this study (Table 1) .
Oral microbiome analysis. Changes in the abundance of phyla are shown in Fig. 1A,B . The ratio between the main two phyla (Firmicutes/Bacteroidetes) is shown in Fig. 1C . CHX increased the abundance of Firmicutes (FDR < 0.001) and Proteobacteria (FDR < 0.001) and lowered the abundance of Bacteroidetes (FDR < 0.001), TM7 (FDR < 0.001), SR1 (FDR < 0.001) and Fusobacteria (FDR = 0.043).
Changes at genus level are presented in Fig. 1D ,E. Within the phylum Firmicutes, the genus Bulleidia (FDR = 0.023) and Streptococcus (FDR = 0.020) were increased after using CHX, while 4 other genera decreased: Clostridium (FDR = 0.035), Megasphera (FDR = 0.001), Catonella (FDR < 0.001) and Lachnoanaerobaculum (FDR < 0.001). Regarding Proteobacteria, CHX led to an increase in Neisseria (FDR = 0.004), Hylemonella (FDR = 0.004) and Eikenella (FDR < 0.001) as well as a reduction in Campylobacter (FDR = 0.035). Changes in Bactoroidetes were led by an increase of Capnocytophaga (FDR < 0.001) and a decrease in Prevotella (FDR < 0.001). A significant reduction in non-assigned genera was found after CHX treatment (FDR = 0.004).
Figures 1F,G show the main changes at family level. Three families within the phylum Firmicutes increased after using CHX: Erysipelotrichaceae (FDR = 0.019), Streptococcaceae (FDR = 0.012) and Carnobacteriaceae (FDR = 0.012), whilst three other families decreased: Clostridiaceae (FDR = 0.027), Mogibacteriaceae (FDR < 0.001) and Lachnospiraceae (FDR = 0.005). The increase of the phylum Proteobacteria after CHX treatment was attributable to an increase in the abundance of 3 families: Neisseriaceae (FDR = 0.003), Comamonadaceae (FDR = 0.004) and Enterobacteriaceae (FDR = 0.005). This was also accompanied by a decrease of the family Campylobacteraceae (FDR = 0.027). On the other hand, lower abundance of the phylum Bacteroidetes was attributable to lower abundance of 2 families: Prevotellaceae (FDR < 0.001) and Paraprevotellaceae (FDR < 0.001) and an increase of the family Flavobacteriaceae (FDR < 0.001). Within the phylum Fusobacteria, the family Fusobacteriaceae (FDR = 0.003) showed the greatest reduction following CHX treatment, whilst in the phylum TM7, F16 (FDR = 0.004) levels showed the greatest reduction. Finally, although the abundance of Actinobacteria did not significantly change after using CHX compared to placebo at phylum level, some families such as Actinomycetaceae (FDR = 0.007) and Corynebacteriaceae (FDR = 0.001) belonging to this phyla were significantly reduced by CHX. Finally, regarding alpha diversity, a significant decrease in the Shannon index was found after using CHX compared to placebo (FDR = 0.001) ( Fig. 2A ). Beta diversity was also significantly affected by CHX as shown by greater dissimilarity of the Bray-Curtis plot compared to placebo ( Fig. 2B ).
Saliva and plasma markers. Salivary pH and buffering capacity were significantly reduced after using CHX compared to placebo ( Fig. 3A,B ). This was accompanied by a significant increase of salivary lactate and glucose ( Fig. 3C ,D). CHX also led to lower oral nitrate-reducing capacity ( Fig. 3E ), which in turn, led to lower saliva and plasma nitrite availability ( Fig. 3F ,H) and increased salivary nitrate concentration ( Fig. 3G ).
Correlations.
We found several moderate correlations between the abundance of oral bacteria and salivary biomarkers after using the placebo and CHX mouthwash ( Fig. 4 ). In the placebo condition, greater abundance of Proteobacteria was negatively correlated with greater ability to form nitrite in the mouth (oral nitrate-reducing capacity) ( Fig. 4A ). Furthermore, greater abundance of Proteobacteria was associated with lower diastolic blood pressure ( Fig. 4D ). Plasma nitrite was negatively correlated with Bacteroidetes ( Fig. 4B ) and positively correlated with Actinobacteria ( Fig. 4E ). Greater abundance of SR1 was also correlated with higher pH salivary values ( Fig. 4C ).
All these correlations changed after using CHX. We only found a positive correlation between Fusobacteria and saliva glucose (Fig. 4F ), and a negative correlation between Actinobacteria and Proteobacteria and lactate and nitrite in saliva ( Fig. 4G ,H), respectively. Blood pressure. When CHX was administered systolic blood pressure increased although it was not statistically significant (Fig. 5A ).
Discussion
This study showed that CHX mouthwash significantly changed the oral microbiome towards greater abundance of Firmicutes and Proteobacteria species, with lower abundance of Bacteroidetes, TM7, SR1 and Fusobacteria. These changes were associated with an increase in oral acidic conditions, represented by lower salivary pH. Saliva lactate and glucose concentrations were also elevated after using CHX. Additionally, CHX disrupted the ability of oral bacteria to reduce nitrate into nitrite, which may support our finding of lower circulatory nitrite bioavailability. www.nature.com/scientificreports www.nature.com/scientificreports/ To the best of our knowledge, this is the first study showing the impact of 7-day use of CHX on the oral microbiome. A large body of literature suggests that mouthwashes with CHX are effective in reducing dental plaque accumulation, gingival inflammation and bleeding [2] [3] [4] . However, the view about oral bacteria and oral health has changed substantially over the last few years 12 . Current approaches, using genome sequencing to identify and quantify the microorganisms in dental biofilms, have revealed a much more complex ecosystem than previously appreciated 13 . Results from this study showed that CHX led to an increase in the abundance of some genera such as Neisseria, Streptococcus and Granulicatella, and lowered the abundance of Actinomyces, but did not affect the www.nature.com/scientificreports www.nature.com/scientificreports/ abundance of Veillonella. However, it remains difficult to determine whether these microbial changes suggest a shift towards a healthy oral environment, or whether they may increase the risk of oral disease, as both increases and decreases in the bacteria associated with caries and periodontal disease have been reported 14 . Consequently, additional studies are required to investigate bacterial communities during different disease states, with and without CHX. Nevertheless, in the current study, we were able to associate genome sequencing measurements with other general markers of oral health, which allowed us to analyse more in detail the impact of mouthwash containing CHX on oral and systemic health.
Lower microbial diversity as represented by the Shannon's index was found after using CHX. This result is in agreement with another recent study showing lower diversity of bacteria colonizing the tongue 7 . These findings are relevant from a dental viewpoint since lower diversity of oral bacteria has been related to greater risk of oral diseases 13 . This may reflect the ecological pressure of lowered environmental pH. Healthy biofilms are associated with an active balance between slow rates of acid production and compensatory alkali generation, resulting in an environment with a broadly neutral pH 12 . Surprisingly, the effect of CHX in salivary pH has only been investigated acutely in both in vivo 15 and in vitro conditions 16 , but, no previous study analysed the impact of this antibacterial compound over a period of days in healthy individuals. Our results showing lower saliva pH after using CHX are relevant, since decreased pH in saliva is associated with demineralization of tooth enamel and risk of caries, tooth loss and other dental problems 17 . Oral pH may differ between different oral conditions: whilst saliva pH is more alkaline in chronic gingivitis, it tends to be more acidic in chronic periodontitis 18 . Thus, in terms of salivary pH, CHX could therefore be more useful for managing gingivitis than periodontitis.
Saliva's composition is another factor to pay attention when analysing the antimicrobial effectiveness of CHX. Several in vitro studies have indicated that saliva has a neutralizing effect on CHX [19] [20] [21] . Since CHX is a strongly cationic molecule it can react with anionic chemicals, resulting in inactivation of antimicrobial activity. We did not analyse the antimicrobial interaction between saliva and CHX in this study, but, we investigated the effect of CHX in several saliva markers. We found that CHX increased saliva lactate concentration and reduced its buffering capacity. These changes are commonly associated with greater risk of oral disease 22 . Regarding bacteria, we found a negative correlation between the phylum Actinobacteria and saliva lactate concentration. This phylum comprises a large variety of Gram-positive bacteria and is known for its high production of bioactive compounds, including those with antimicrobial activity such as lantibiotics 23 . For instance, Nisin is one of the best known antibiotics for its highly effective bactericidal activity against most lactic acid bacteria 24 . Another important bacterial change associated with CHX administration was an increase of the major phyla Firmicutes, mainly comprised of an increase of the genus Streptococcus. This genus contains several families of lactic acid bacteria that are able to produce large quantities of this compound in the mouth 25 . On the other hand, we also found a significant www.nature.com/scientificreports www.nature.com/scientificreports/ decrease in the abundance of Bacteroidetes after using CHX. This was the second most abundant phyla in the oral cavity and some genera from this phyla such as Veillonella has been shown to be important in maintaining the acid/base conditions in the mouth 26 . Overall, these findings indicate that CHX promotes acidification of saliva by changing the ratio abundance of different families of bacteria that are essential to maintain the acid/base conditions in the mouth of healthy people.
Oral nitrite synthesis is another factor to take into account, with regards to the acid/base conditions of the oral cavity 27 . Nitrite is a nitrogen compound that forms naturally in the mouth by the action of oral bacteria that can use exogenous (diet) or endogenous (nitric oxide synthesis) nitrate sources 28 . Species within the genus Veillonella and Actinomyces have been suggested to lead this reaction in the oral cavity 29 . Importantly, CHX had a detrimental effect lowering the abundance of bacteria from these groups and reducing nitrite availability. Thus, the detrimental effect of CHX on oral nitrite synthesis is another key point requiring further attention by dental professionals, since nitrite has been shown to have an inhibitory effect in the growth of periodontal bacteria which can also help to reduce the acid production from these strains 27, 30 .
On the other hand, nitrite synthesis in the mouth has been shown to play a key role in cardiovascular control by enhancing circulatory nitrite availability. The vasodilatory effects of nitrite are well described by previous studies using intra-arterial infusions or dietary supplements with this anion 31, 32 . Some recent studies, but not all 9, 33 , have also found that the use of CHX mouthwash from 3 to 7 days led to higher blood pressure in healthy 8 and hypertensive individuals 34 . Participants from these studies had higher values of blood pressure compared to participants in our current study. In agreement with our results, Sundqvist et al. 33 did not show a raise in blood pressure in a young and healthy group of females after using CHX for three days. Additional studies are required to improve our understanding about the hypertensive effect of CHX in males and females with different resting blood pressure levels and physiological status, especially, after new evidence has shown that CHX raised the mortality rate in hospitalized patients 35 . Overall, current studies seem to indicate that the use of CHX mouthwash leads to an increase of blood pressure, and this may be more accentuated in people with high blood pressure levels 8, 9, 11, 33 .
This study has some limitations. For instance, it would be interesting to analyse the effect of CHX in patients with different oral health conditions such as gingivitis or periodontitis. We assessed the oral health status of participants using a medical questionnaire, but it would be useful to undertake a full oral and dental examination, to analyse more in detail the concurrent effect of CHX on markers of periodontal health. Treatments were not randomized in this study due to the lack of available data indicating the time needed for the full recovery of the oral microbiome after one-week use of CHX. Consequently, there was not a wash out period between treatments. Furthermore, we analysed the microbiome in saliva as it provides an average of the oral microbiome, but bacterial communities can significantly differ among sites in distinct microbial niches in the oral cavity, therefore where the effects of CHX may also differ.
In conclusion this study indicates that a 7-day use of CHX mouthwash has a significant impact on the oral microbiome, as well as shift to an acidic environment, favourable for increased dental caries, and a reduction of the amount of oral nitrate-reducing bacteria, which contribute to cardiovascular health. Thus, these findings add to the growing body of evidence that the applications of CHX mouthwash should be more carefully considered, and that CHX could have detrimental effects on the healthy microbiome, and in turn cardiovascular health, requiring further investigation.
Methods
This study was approved by the Ethics Committee of the Faculty of Health & Human Sciences (University of Plymouth) and was carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving human subjects. All the participants provided written consent to participate in this study. This study was also registered on http://www.clinicaltrials.gov (NCT03871777; date of registration: 12/03/2019). Parts of the data presented herein were extracted from a study that examined the dietary consumption of nitrate in healthy vegetarian and omnivore subjects and the impact of inhibiting the nitrate-reducing activity of oral bacteria using CHX mouthwash in blood pressure 9 .
Main protocol. Following a single blinded, non-randomized, cross over design participants visited the laboratory twice. Before the first trial, each participant received 14 tubes containing 10 mL placebo mouthwash (ultrapure unflavoured water), with which they rinsed their mouth for 1 min, twice a day for 7 days taking the final tube the night before the trial. Individuals were excluded from this study if they were smokers, using mouthwash or tongue scrapes, suffering from gingivitis or periodontitis, or exhibited a medical condition (e.g hypertension, diabetes). For standardisation, they were also given the same toothpaste to use throughout the duration of the study. Participants visited the laboratory on the eighth day between 8 and 10 am, having fasted overnight. Additionally, at least 24 h prior to their visit, they were sent written instructions via email to avoid drinks containing caffeine, such as tea or coffee, before the test and to refrain from strenuous exercise. Basic anthropometrical (weight and height) and physiological (blood pressure) parameters were measured before the collection of a plasma sample and a non-stimulated salivary sample (3 mL) as previously indicated 9 . Then, the oral nitrate-reducing capacity was also measured. At the end of the visit, the participant was given a further one-week supply of antibacterial mouthwash containing 0.2% CHX (Corsodyl Mint, GlaxoSmithKline, UK), instructed to use it as per the previous mouthwash (1 min, twice a day) and requested to return to the laboratory in 7 days to repeat all measurements in the same order.
Blood pressure measurement. Participants rested in a supine position for 30 min, before three successive readings were taken (four if variation in systolic or diastolic blood pressure of >4 mmHg was found), using an oscillometric device (Connex ProBP 3400 Digital Blood Pressure Device, Welch Allyn UK Ltd.) with 1 min rest between readings. The second and third readings were averaged to determine mean clinical blood pressure.
Statistical analyses.
General data are presented as mean (95% confidence interval). Normal distribution of the sample was assessed using Shapiro-Wilk test. Differences between treatments (placebo vs CHX) were analysed using paired t-tests (data normally distributed) or Wilcoxon test (data non-normally distributed). Operational Taxonomic Units (OTUs) assigned to the major salivary bacterial phyla, and genera were analysed using the linear discriminant analysis (LDA) effect size (LEfSe) method 37 . The False Discovery Rate (FDR) was used at an alpha of 0.05 as previously indicated 38 . The Pearson correlation test was used to investigate relationship between relative oral bacterial abundance (OTUs %) and salivary markers. Bioinformatics analysis was performed using the OTUs_biom table generated in with MicrobiomeAnalysit 39 .
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. All data generated or analysed during this study are included in this published article.
